Trademark: 79312543
Word
ELIMSA
Status
Registered
Status Code
700
Status Date
Tuesday, March 7, 2023
Serial Number
79312543
Registration Number
6993636
Registration Date
Tuesday, March 7, 2023
Mark Type
4000
Filing Date
Thursday, February 18, 2021
Published for Opposition
Tuesday, December 20, 2022

Trademark Owner History
YYZ Pharmatech, Inc. - Original Registrant

Classifications
9 Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, test tubes, microscope slides, incubators, laboratory robots, and chromatography supports being chromatography apparatus for laboratory use; Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, medical diagnostic simulators for use as teaching aids for detecting pathogens, DNA analysis, and chromatography; electrophoresis laboratory apparatus and instruments for extracting biomolecules within enzyme-linked immunosorbent assays, immunoblots, polymerase chain reactions (PCR), hybridization, binding assays, nucleic acids, DNA, RNA, proteins, and antigens, not for medical purposes; analytical apparatus in the nature of an automated slide stainer for use in medical laboratories; and replacement parts and fittings therefor
5 Diagnostic and test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic and test kits, namely, drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of protein, DNA, RNA, antibody, nanobody, aptamer, peptide, and biopolymer; Diagnostic and test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, oncology being cancers, neurological diseases, immunological diseases, cardiovascular diseases, genetic diseases, environmental diseases, dietary diseases, and pathogens; diagnostic reagents for medicinal use; medical diagnostic reagents; Kits for testing of body fluids, namely, medical diagnostic reagents and assays for testing body fluids, tissues or cells for microorganisms; Kits for testing of body fluids, namely, medical diagnostic reagents and assays for testing of body fluids and tissue of cells for human health, capture and detection reagents for environmental use, human health, agriculture, food and nutrition; laboratory and scientific equipment for detection, quantification of analytes, biopolymers or germs, and diagnosis of virus, disease and pathogens, namely, diagnostic media for bacteriological cultures, medical diagnostic test media in the form of strip, threads, multi-well plates, microbeads, nanobeads, for measuring pathological condition, phenotypic condition, genotypic condition; and replacement parts and fittings therefor

Trademark Events
Jul 3, 2023
Final Decision Transaction Processed By Ib
Jun 11, 2023
Final Disposition Notice Sent To Ib
Jun 11, 2023
Final Disposition Processed
Jun 7, 2023
Final Disposition Notice Created, To Be Sent To Ib
Mar 7, 2023
Notice Of Registration Confirmation Emailed
Mar 7, 2023
Registered-Principal Register
Dec 21, 2022
Notification Processed By Ib
Dec 20, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 20, 2022
Published For Opposition
Nov 30, 2022
Notification Of Possible Opposition Sent To Ib
Nov 30, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 30, 2022
Notification Of Notice Of Publication E-Mailed
Nov 27, 2022
Notification Of Possible Opposition - Processed By Ib
Nov 15, 2022
Approved For Pub - Principal Register
Nov 14, 2022
Teas/Email Correspondence Entered
Nov 14, 2022
Correspondence Received In Law Office
Nov 14, 2022
Assigned To Lie
Nov 9, 2022
Notification Of Possible Opposition Sent To Ib
Nov 9, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 2, 2022
Teas Request For Reconsideration Received
Nov 2, 2022
Ex Parte Appeal-Instituted
Nov 2, 2022
Jurisdiction Restored To Examining Attorney
Nov 2, 2022
Exparte Appeal Received At Ttab
May 3, 2022
Notification Of Final Refusal Emailed
May 3, 2022
Final Refusal E-Mailed
May 3, 2022
Final Refusal Written
Apr 4, 2022
Teas/Email Correspondence Entered
Apr 4, 2022
Correspondence Received In Law Office
Apr 4, 2022
Teas Response To Office Action Received
Mar 9, 2022
Assigned To Examiner
Oct 30, 2021
Refusal Processed By Ib
Oct 5, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Oct 5, 2021
Refusal Processed By Mpu
Sep 21, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 20, 2021
Non-Final Action Written
Sep 14, 2021
Assigned To Examiner
Jun 12, 2021
Application Filing Receipt Mailed
Jun 8, 2021
New Application Office Supplied Data Entered
Jun 3, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24